Zobrazeno 1 - 10
of 86
pro vyhledávání: '"O, Jurkovicová"'
Publikováno v:
Vnitrni lekarstvi. 56(8)
NT-proBNP, a well-established diagnostic and prognostic marker in clinical practice, is significantly elevated in individuals with atrial fibrillation (AF), even in absence of heart failure or major structural heart disease.The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcc49ebe9fae05718422379319bcdb76
https://pubmed.ncbi.nlm.nih.gov/20845610
https://pubmed.ncbi.nlm.nih.gov/20845610
Publikováno v:
Vnitrni lekarstvi. 54(6)
To analyze factors after successful direct-current cardioversion in patients with atrial fibrillation and to explore late recurrences of the arrhythmia.Forty-three patients with atrial fibrillation without associated valvular heart disease, who under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07c0a9d2b6665126b897a36704c0c2b5
https://pubmed.ncbi.nlm.nih.gov/18672570
https://pubmed.ncbi.nlm.nih.gov/18672570
Autor:
J, Dúbrava, O, Jurkovicová
Publikováno v:
Vnitrni lekarstvi. 49(4)
Adenosine is a drug with unique clinical and electrophysiological properties. Despite this, its use in Slovakia is rare. The decisive reason, besides its price, is the physicians fear of potential adverse effects and their limited knowledge regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3daf7ad4db4c589e37f366b84a51376
https://pubmed.ncbi.nlm.nih.gov/12793042
https://pubmed.ncbi.nlm.nih.gov/12793042
[Early diagnosis and reasons for not administering thrombolytic therapy in acute myocardial infarct]
Publikováno v:
Vnitrni lekarstvi. 48(2)
In Slovakia we are lacking data on early (before examination of serum markers of myocardial necrosis) pertaining to thrombolytic treatment (TLL) which is inevitable in case of acute myocardial infarction (AIM) as well as data on the reasons why TLL i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0604a86e5f71733e43e09fe9f6eebcc0
https://pubmed.ncbi.nlm.nih.gov/11949218
https://pubmed.ncbi.nlm.nih.gov/11949218
Publikováno v:
Bratislavske lekarske listy. 98(7-8)
Sudden cardiac death (SCD) in the setting of acute myocardial infarction (AMI) remains an actual problem. There is a very close relationship between ventricular arrhythmias and SCD in AMI. Malignant ventricular arrhythmias, such as ventricular fibril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc15b4000c3b3652a3cdf8fbe6b4ffee
https://pubmed.ncbi.nlm.nih.gov/9471331
https://pubmed.ncbi.nlm.nih.gov/9471331
Autor:
O, Jurkovicová, S, Cagán
Publikováno v:
Bratislavske lekarske listy. 98(7-8)
Non-pharmacologic therapy has revolutionized the management of arrhythmias and prevention of sudden cardiac death (SCD). Of particular importance is the introduction of radiofrequent catheter ablation (RFCA) and implantable cardioverter-defibrillator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30b4f2b3ba513be159da7ac1104a725d
https://pubmed.ncbi.nlm.nih.gov/9471337
https://pubmed.ncbi.nlm.nih.gov/9471337
Autor:
S, Cagán, O, Jurkovicová
Publikováno v:
Bratislavske lekarske listy. 98(7-8)
Heart rhythm disturbances represent one of the most important causes of cardiovascular mortality and, in particular, sudden cardiac arrhythmic death. The persistent actuality of arrhythmias is currently characterized by: 1) better knowledge of pathog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d4659738503a2562a17cb19c7af0bad
https://pubmed.ncbi.nlm.nih.gov/9471336
https://pubmed.ncbi.nlm.nih.gov/9471336
Autor:
O, Jurkovicová, S, Cagán
Publikováno v:
Bratislavske lekarske listy. 97(7)
Besides the thrombolytic therapy several adjuvant therapeutic measures were identified which significantly improve the prognosis of patients with acute myocardial infarction (AMI). These measures include the treatment by means of acetylsalicylic acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5d3e6af445f8d279cc72b7c977e286f
https://pubmed.ncbi.nlm.nih.gov/8925311
https://pubmed.ncbi.nlm.nih.gov/8925311
Publikováno v:
Vnitrni lekarstvi. 41(9)
Holter monitoring (HM) of the electrocardiogram (ECG) is used currently for the management of patients with ventricular preexcitation (PE). It makes it possible to detect inconstant PE which is considered a marker of a favourable clinical development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0ca4771368571412700e4d6623a9a7f
https://pubmed.ncbi.nlm.nih.gov/7483356
https://pubmed.ncbi.nlm.nih.gov/7483356
Publikováno v:
Bratislavske lekarske listy. 96(8)
It is known that patients with preexcitation of ventricles (PE) have a predisposition to paroxysmal supraventricular tachyarrhythmias (PSVT). There is a relatively small amount of knowledge concerning the occurrence and clinical significance of other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b908b3a91c8d30f4837f97d8e8ab57a
https://pubmed.ncbi.nlm.nih.gov/8556351
https://pubmed.ncbi.nlm.nih.gov/8556351